MicroRNA-24 is a novel regulator of aldosterone and cortisol production in the human adrenal cortex

Hypertension

Volumn 62, Issue 3, 2013, Pages 572-578

  Robertson, Stacy ^a   Mackenzie, Scott M ^a   Alvarez Madrazo, Samantha ^a   Diver, Louise A ^a   Lin, Junjun ^a   Stewart, Paul M ^b   Fraser, Robert ^a   Connell, John M ^c   Davies, Eleanor ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

aldosterone; aldosterone synthase; cortisol; hypertension; microRNAs; steroid 11 beta hydroxylase

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; CYP11B2 PROTEIN; DICER; HYDROCORTISONE; MICRORNA 24; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADRENAL CORTEX; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; HYDROCORTISONE RELEASE; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA BINDING; RNA PROCESSING; VALIDATION STUDY;

ALDOSTERONE; ALDOSTERONE SYNTHASE; CORTISOL; HYPERTENSION; MICRORNAS; STEROID 11-BETA-HYDROXYLASE;

ADENOMA; ADRENAL CORTEX; ADRENAL CORTEX NEOPLASMS; ALDOSTERONE; ALDOSTERONE SYNTHASE; CELL LINE; DEAD-BOX RNA HELICASES; GENE EXPRESSION PROFILING; HUMANS; HYDROCORTISONE; MICRORNAS; RIBONUCLEASE III; RNA, SMALL INTERFERING; STEROID 11-BETA-HYDROXYLASE;

EID: 84883291331     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.01102     Document Type: Article

References (35)

1. Whitworth JA, Mangos GJ, Kelly JJ. Cushing, cortisol, and cardiovascular disease. Hypertension. 2000;36:912-916.
2. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005;45:1243-1248.
3. Rossi GP, Bernini G, Caliumi C, et al. PAPY Study Investigators. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48:2293-2300.
4. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young WF Jr. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab. 2004;89:1045-1050.
5. Vasan RS, Evans JC, Larson MG, Wilson PW, Meigs JB, Rifai N, Benjamin EJ, Levy D. Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med. 2004;351:33-41.
6. Mornet E, Dupont J, Vitek A, White PC. Characterization of two genes encoding human steroid 11 β-hydroxylase (P-450(11) β). J Biol Chem. 1989;264:20961-20967.
7. Lenzini L, Seccia TM, Aldighieri E, Belloni AS, Bernante P, Giuliani L, Nussdorfer GG, Pessina AC, Rossi GP. Heterogeneity of aldosterone-producing adenomas revealed by a whole transcriptome analysis. Hypertension. 2007;50:1106-1113.
8. Wang T, Satoh F, Morimoto R, Nakamura Y, Sasano H, Auchus RJ, Edwards MA, Rainey WE. Gene expression profiles in aldosterone-producing adenomas and adjacent adrenal glands. Eur J Endocrinol. 2011;164:613-619.
9. Alvarez-Madrazo S, Padmanabhan S, Mayosi BM, Watkins H, Avery P, Wallace AM, Fraser R, Davies E, Keavney B, Connell JM. Familial and phenotypic associations of the aldosterone Renin ratio. J Clin Endocrinol Metab. 2009;94:4324-4333.
10. Alvarez-Madrazo S, Mackenzie SM, Davies E, et al. Common polymorphisms in the CYP11B1 and CYP11B2 genes: Evidence for a digenic influence on hypertension. Hypertension. 2013;61:232-239.
11. Davies E, Holloway CD, Ingram MC, Inglis GC, Friel EC, Morrison C, Anderson NH, Fraser R, Connell JM. Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. Hypertension. 1999;33:703-707.
12. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15-20.
13. Kim VN. MicroRNA biogenesis: Coordinated cropping and dicing. Nat Rev Mol Cell Biol. 2005;6:376-385.
14. Huang C-CJ, Yao HHC. Inactivation of Dicer1 in Steroidogenic factor 1-positive cells reveals tissue-specific requirement for Dicer1 in adrenal, testis, and ovary. BMC Dev Biol. 2010;10:66.
15. Soon PS, Tacon LJ, Gill AJ, Bambach CP, Sywak MS, Campbell PR, Yeh MW, Wong SG, Clifton-Bligh RJ, Robinson BG, Sidhu SB. miR-195 and miR-483-5p identified as predictors of poor prognosis in adrenocortical cancer. Clin Cancer Res. 2009;15:7684-7692.
16. Romero DG, Plonczynski MW, Carvajal CA, Gomez-Sanchez EP, Gomez-Sanchez CE. Microribonucleic acid-21 increases aldosterone secretion and proliferation in H295R human adrenocortical cells. Endocrinology. 2008;149:2477-2483.
17. Rainey WE, Bird IM, Mason JI. The NCI-H295 cell line: A pluripotent model for human adrenocortical studies. Mol Cell Endocrinol. 1994;100:45-50.
18. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402-408.
19. Ingram M, Fraser R. Plasma corticosteroid profiling: Brief opinion of its current status in clinical diagnosis and research. Expert Rev Endocrinol Metab. 2010;5:181-188.
20. Bassett MH, Zhang Y, Clyne C, White PC, Rainey WE. Differential regulation of aldosterone synthase and 11β-hydroxylase transcription by steroidogenic factor-1. J Mol Endocrinol. 2002;28:125-135.
21. Bassett MH, Zhang Y, White PC, Rainey WE. Regulation of human CYP11B2 and CYP11B1: Comparing the role of the common CRE/Ad1 element. Endocr Res. 2000;26:941-951.
22. Schmitz KJ, Helwig J, Bertram S, Sheu SY, Suttorp AC, Seggewiss J, Willscher E, Walz MK, Worm K, Schmid KW. Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours. J Clin Pathol. 2011;64:529-535.
23. Tömböl Z, Szabó PM, Molnár V, Wiener Z, Tölgyesi G, Horányi J, Riesz P, Reismann P, Patócs A, Likó I, Gaillard RC, Falus A, Rácz K, Igaz P. Integrative molecular bioinformatics study of human adrenocortical tumors: MicroRNA, tissue-specific target prediction, and pathway analysis. Endocr Relat Cancer. 2009;16:895-906.
24. Iliopoulos D, Bimpaki EI, Nesterova M, Stratakis CA. MicroRNA signature of primary pigmented nodular adrenocortical disease: Clinical correlations and regulation of Wnt signaling. Cancer Res. 2009;69:3278-3282.
25. Bimpaki EI, Iliopoulos D, Moraitis A, Stratakis CA. MicroRNA signature in massive macronodular adrenocortical disease and implications for adrenocortical tumourigenesis. Clin Endocrinol (Oxf). 2010;72:744-751.
26. Ritchie W, Flamant S, Rasko JE. mimiRNA: A microRNA expression profiler and classification resource designed to identify functional correlations between microRNAs and their targets. Bioinformatics. 2010;26:223-227.
27. Bartel DP. MicroRNAs: Target recognition and regulatory functions. Cell. 2009;136:215-233.
28. Shin C, Nam JW, Farh KK, Chiang HR, Shkumatava A, Bartel DP. Expanding the microRNA targeting code: Functional sites with centered pairing. Mol Cell. 2010;38:789-802.
29. Chhabra R, Dubey R, Saini N. Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseases. Mol Cancer. 2010;9:232.
30. Díaz-Perales A, Quesada V, Sánchez LM, Ugalde AP, Suárez MF, Fueyo A, López-Otín C. Identification of human aminopeptidase O, a novel metalloprotease with structural similarity to aminopeptidase B and leukotriene A4 hydrolase. J Biol Chem. 2005;280:14310- 14317.
31. Mitsui T, Nomura S, Okada M, Ohno Y, Kobayashi H, Nakashima Y, Murata Y, Takeuchi M, Kuno N, Nagasaka T, O-Wang J, Cooper MD, Mizutani S. Hypertension and angiotensin II hypersensitivity in aminopeptidase A-deficient mice. Mol Med. 2003;9:57-62.
32. Ahmad S, Ward PE. Role of aminopeptidase activity in the regulation of the pressor activity of circulating angiotensins. J Pharmacol Exp Ther. 1990;252:643-650.
33. Yatabe J, Yoneda M, Yatabe MS, Watanabe T, Felder RA, Jose PA, Sanada H. Angiotensin III stimulates aldosterone secretion from adrenal gland partially via angiotensin II type 2 receptor but not angiotensin II type 1 receptor. Endocrinology. 2011;152:1582-1588.
34. Lal A, Kim HH, Abdelmohsen K, Kuwano Y, Pullmann R Jr, Srikantan S, Subrahmanyam R, Martindale JL, Yang X, Ahmed F, Navarro F, Dykxhoorn D, Lieberman J, Gorospe M. p16(INK4a) translation suppressed by miR-24. PLoS One. 2008;3:e1864.
35. Qian L, Van Laake LW, Huang Y, Liu S, Wendland MF, Srivastava D. miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J Exp Med. 2011;208:549-560.